ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Complement C5 Recombinant Monoclonal Antibody Market Research Report 2026
Published Date: 2026-02-10
|
Report Code: QYRE-Auto-5L18356
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Complement C5 Recombinant Monoclonal Antibody Market Research Report 2024
BUY CHAPTERS

Global Complement C5 Recombinant Monoclonal Antibody Market Research Report 2026

Code: QYRE-Auto-5L18356
Report
2026-02-10
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Regeneron Pharmaceuticals
Alexion Pharmaceuticals
Amgen Inc
Samsung Bioepis
Roche

Complement C5 Recombinant Monoclonal Antibody Market

The global Complement C5 Recombinant Monoclonal Antibody market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Complement C5 Recombinant Monoclonal Antibody competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Complement C5 recombinant monoclonal antibody is a biologic drug designed to specifically target and block complement protein C5, which is a critical component of the immune system’s complement pathway.This class of drugs is used to treat diseases caused by excessive complement activation, such as paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and neuromyelitis optica spectrum disorder (NMOSD).
The North American market for Complement C5 Recombinant Monoclonal Antibody is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Complement C5 Recombinant Monoclonal Antibody is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Complement C5 Recombinant Monoclonal Antibody include Regeneron Pharmaceuticals, Alexion Pharmaceuticals, Amgen, Samsung Bioepis, Roche, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Complement C5 Recombinant Monoclonal Antibody market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Complement C5 Recombinant Monoclonal Antibody. The Complement C5 Recombinant Monoclonal Antibody market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Complement C5 Recombinant Monoclonal Antibody market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Complement C5 Recombinant Monoclonal Antibody manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Complement C5 Recombinant Monoclonal Antibody Market Report

Report Metric Details
Report Name Complement C5 Recombinant Monoclonal Antibody Market
Segment by Type
  • Crovalimab
  • Ravulizumab
  • Eculizumab
  • Pozelimab
  • Others
by Application
  • PNH
  • aHUS
  • CD55 Deficiency
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Regeneron Pharmaceuticals, Alexion Pharmaceuticals, Amgen, Samsung Bioepis, Roche
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Complement C5 Recombinant Monoclonal Antibody manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Complement C5 Recombinant Monoclonal Antibody sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Complement C5 Recombinant Monoclonal Antibody Market report?

Ans: The main players in the Complement C5 Recombinant Monoclonal Antibody Market are Regeneron Pharmaceuticals, Alexion Pharmaceuticals, Amgen, Samsung Bioepis, Roche

What are the Application segmentation covered in the Complement C5 Recombinant Monoclonal Antibody Market report?

Ans: The Applications covered in the Complement C5 Recombinant Monoclonal Antibody Market report are PNH, aHUS, CD55 Deficiency, Others

What are the Type segmentation covered in the Complement C5 Recombinant Monoclonal Antibody Market report?

Ans: The Types covered in the Complement C5 Recombinant Monoclonal Antibody Market report are Crovalimab, Ravulizumab, Eculizumab, Pozelimab, Others

1 Complement C5 Recombinant Monoclonal Antibody Market Overview
1.1 Product Definition
1.2 Complement C5 Recombinant Monoclonal Antibody by Type
1.2.1 Global Complement C5 Recombinant Monoclonal Antibody Market Value by Type: 2025 vs 2032
1.2.2 Crovalimab
1.2.3 Ravulizumab
1.2.4 Eculizumab
1.2.5 Pozelimab
1.2.6 Others
1.3 Complement C5 Recombinant Monoclonal Antibody by Application
1.3.1 Global Complement C5 Recombinant Monoclonal Antibody Market Value by Application: 2025 vs 2032
1.3.2 PNH
1.3.3 aHUS
1.3.4 CD55 Deficiency
1.3.5 Others
1.4 Global Complement C5 Recombinant Monoclonal Antibody Market Size Estimates and Forecasts
1.4.1 Global Complement C5 Recombinant Monoclonal Antibody Revenue 2021–2032
1.4.2 Global Complement C5 Recombinant Monoclonal Antibody Sales 2021–2032
1.4.3 Global Complement C5 Recombinant Monoclonal Antibody Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Complement C5 Recombinant Monoclonal Antibody Market Competition by Manufacturers
2.1 Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Manufacturers (2021–2026)
2.2 Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Complement C5 Recombinant Monoclonal Antibody Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Complement C5 Recombinant Monoclonal Antibody, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Complement C5 Recombinant Monoclonal Antibody, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Complement C5 Recombinant Monoclonal Antibody, Product Types and Applications
2.7 Global Key Manufacturers of Complement C5 Recombinant Monoclonal Antibody, Date of Entry into the Industry
2.8 Global Complement C5 Recombinant Monoclonal Antibody Market Competitive Situation and Trends
2.8.1 Global Complement C5 Recombinant Monoclonal Antibody Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Complement C5 Recombinant Monoclonal Antibody Players Market Share by Revenue
2.8.3 Global Complement C5 Recombinant Monoclonal Antibody Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Complement C5 Recombinant Monoclonal Antibody Market Scenario by Region
3.1 Global Complement C5 Recombinant Monoclonal Antibody Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Complement C5 Recombinant Monoclonal Antibody Sales by Region: 2021–2032
3.2.1 Global Complement C5 Recombinant Monoclonal Antibody Sales by Region: 2021–2026
3.2.2 Global Complement C5 Recombinant Monoclonal Antibody Sales by Region: 2027–2032
3.3 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Region: 2021–2032
3.3.1 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Region: 2021–2026
3.3.2 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Region: 2027–2032
3.4 North America Complement C5 Recombinant Monoclonal Antibody Market Facts & Figures by Country
3.4.1 North America Complement C5 Recombinant Monoclonal Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021–2032)
3.4.3 North America Complement C5 Recombinant Monoclonal Antibody Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Complement C5 Recombinant Monoclonal Antibody Market Facts & Figures by Country
3.5.1 Europe Complement C5 Recombinant Monoclonal Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021–2032)
3.5.3 Europe Complement C5 Recombinant Monoclonal Antibody Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Complement C5 Recombinant Monoclonal Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific Complement C5 Recombinant Monoclonal Antibody Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Complement C5 Recombinant Monoclonal Antibody Sales by Region (2021–2032)
3.6.3 Asia Pacific Complement C5 Recombinant Monoclonal Antibody Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Complement C5 Recombinant Monoclonal Antibody Market Facts & Figures by Country
3.7.1 Latin America Complement C5 Recombinant Monoclonal Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021–2032)
3.7.3 Latin America Complement C5 Recombinant Monoclonal Antibody Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021–2032)
3.8.3 Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021–2032)
4.1.1 Global Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021–2026)
4.1.2 Global Complement C5 Recombinant Monoclonal Antibody Sales by Type (2027–2032)
4.1.3 Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Type (2021–2032)
4.2 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Type (2021–2032)
4.2.1 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Type (2021–2026)
4.2.2 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Type (2027–2032)
4.2.3 Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Type (2021–2032)
4.3 Global Complement C5 Recombinant Monoclonal Antibody Price by Type (2021–2032)
5 Segment by Application
5.1 Global Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021–2032)
5.1.1 Global Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021–2026)
5.1.2 Global Complement C5 Recombinant Monoclonal Antibody Sales by Application (2027–2032)
5.1.3 Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Application (2021–2032)
5.2 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Application (2021–2032)
5.2.1 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Application (2021–2026)
5.2.2 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Application (2027–2032)
5.2.3 Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Application (2021–2032)
5.3 Global Complement C5 Recombinant Monoclonal Antibody Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Regeneron Pharmaceuticals
6.1.1 Regeneron Pharmaceuticals Company Information
6.1.2 Regeneron Pharmaceuticals Description and Business Overview
6.1.3 Regeneron Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Regeneron Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Product Portfolio
6.1.5 Regeneron Pharmaceuticals Recent Developments/Updates
6.2 Alexion Pharmaceuticals
6.2.1 Alexion Pharmaceuticals Company Information
6.2.2 Alexion Pharmaceuticals Description and Business Overview
6.2.3 Alexion Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Alexion Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Product Portfolio
6.2.5 Alexion Pharmaceuticals Recent Developments/Updates
6.3 Amgen
6.3.1 Amgen Company Information
6.3.2 Amgen Description and Business Overview
6.3.3 Amgen Complement C5 Recombinant Monoclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Amgen Complement C5 Recombinant Monoclonal Antibody Product Portfolio
6.3.5 Amgen Recent Developments/Updates
6.4 Samsung Bioepis
6.4.1 Samsung Bioepis Company Information
6.4.2 Samsung Bioepis Description and Business Overview
6.4.3 Samsung Bioepis Complement C5 Recombinant Monoclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Samsung Bioepis Complement C5 Recombinant Monoclonal Antibody Product Portfolio
6.4.5 Samsung Bioepis Recent Developments/Updates
6.5 Roche
6.5.1 Roche Company Information
6.5.2 Roche Description and Business Overview
6.5.3 Roche Complement C5 Recombinant Monoclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Roche Complement C5 Recombinant Monoclonal Antibody Product Portfolio
6.5.5 Roche Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Complement C5 Recombinant Monoclonal Antibody Industry Chain Analysis
7.2 Complement C5 Recombinant Monoclonal Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Complement C5 Recombinant Monoclonal Antibody Production Mode & Process Analysis
7.4 Complement C5 Recombinant Monoclonal Antibody Sales and Marketing
7.4.1 Complement C5 Recombinant Monoclonal Antibody Sales Channels
7.4.2 Complement C5 Recombinant Monoclonal Antibody Distributors
7.5 Complement C5 Recombinant Monoclonal Antibody Customer Analysis
8 Complement C5 Recombinant Monoclonal Antibody Market Dynamics
8.1 Complement C5 Recombinant Monoclonal Antibody Industry Trends
8.2 Complement C5 Recombinant Monoclonal Antibody Market Drivers
8.3 Complement C5 Recombinant Monoclonal Antibody Market Challenges
8.4 Complement C5 Recombinant Monoclonal Antibody Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Regeneron Pharmaceuticals
Alexion Pharmaceuticals
Amgen Inc
Samsung Bioepis
Roche
List of Tables
 Table 1. Global Complement C5 Recombinant Monoclonal Antibody Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Complement C5 Recombinant Monoclonal Antibody Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Complement C5 Recombinant Monoclonal Antibody Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Complement C5 Recombinant Monoclonal Antibody Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Complement C5 Recombinant Monoclonal Antibody Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Complement C5 Recombinant Monoclonal Antibody Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Complement C5 Recombinant Monoclonal Antibody Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Complement C5 Recombinant Monoclonal Antibody, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Complement C5 Recombinant Monoclonal Antibody, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Complement C5 Recombinant Monoclonal Antibody, Product Types and Applications
 Table 12. Global Key Manufacturers of Complement C5 Recombinant Monoclonal Antibody, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Complement C5 Recombinant Monoclonal Antibody Companies by Tier (Tier 1, Tier 2, Tier 3), based on Complement C5 Recombinant Monoclonal Antibody Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Complement C5 Recombinant Monoclonal Antibody Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Complement C5 Recombinant Monoclonal Antibody Sales by Region (K Units), 2021–2026
 Table 18. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Region (2021–2026)
 Table 19. Global Complement C5 Recombinant Monoclonal Antibody Sales by Region (K Units), 2027–2032
 Table 20. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Region (2027–2032)
 Table 21. Global Complement C5 Recombinant Monoclonal Antibody Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Region (2021–2026)
 Table 23. Global Complement C5 Recombinant Monoclonal Antibody Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Region (2027–2032)
 Table 25. North America Complement C5 Recombinant Monoclonal Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Complement C5 Recombinant Monoclonal Antibody Sales by Country (K Units), 2021–2026
 Table 27. North America Complement C5 Recombinant Monoclonal Antibody Sales by Country (K Units), 2027–2032
 Table 28. North America Complement C5 Recombinant Monoclonal Antibody Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Complement C5 Recombinant Monoclonal Antibody Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Complement C5 Recombinant Monoclonal Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Complement C5 Recombinant Monoclonal Antibody Sales by Country (K Units), 2021–2026
 Table 32. Europe Complement C5 Recombinant Monoclonal Antibody Sales by Country (K Units), 2027–2032
 Table 33. Europe Complement C5 Recombinant Monoclonal Antibody Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Complement C5 Recombinant Monoclonal Antibody Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Complement C5 Recombinant Monoclonal Antibody Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Complement C5 Recombinant Monoclonal Antibody Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Complement C5 Recombinant Monoclonal Antibody Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Complement C5 Recombinant Monoclonal Antibody Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Complement C5 Recombinant Monoclonal Antibody Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Complement C5 Recombinant Monoclonal Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Complement C5 Recombinant Monoclonal Antibody Sales by Country (K Units), 2021–2026
 Table 42. Latin America Complement C5 Recombinant Monoclonal Antibody Sales by Country (K Units), 2027–2032
 Table 43. Latin America Complement C5 Recombinant Monoclonal Antibody Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Complement C5 Recombinant Monoclonal Antibody Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Complement C5 Recombinant Monoclonal Antibody Sales (K Units) by Type (2021–2026)
 Table 51. Global Complement C5 Recombinant Monoclonal Antibody Sales (K Units) by Type (2027–2032)
 Table 52. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Type (2021–2026)
 Table 53. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Type (2027–2032)
 Table 54. Global Complement C5 Recombinant Monoclonal Antibody Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Complement C5 Recombinant Monoclonal Antibody Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Type (2021–2026)
 Table 57. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Type (2027–2032)
 Table 58. Global Complement C5 Recombinant Monoclonal Antibody Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Complement C5 Recombinant Monoclonal Antibody Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Complement C5 Recombinant Monoclonal Antibody Sales (K Units) by Application (2021–2026)
 Table 61. Global Complement C5 Recombinant Monoclonal Antibody Sales (K Units) by Application (2027–2032)
 Table 62. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Application (2021–2026)
 Table 63. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Application (2027–2032)
 Table 64. Global Complement C5 Recombinant Monoclonal Antibody Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Complement C5 Recombinant Monoclonal Antibody Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Application (2021–2026)
 Table 67. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Application (2027–2032)
 Table 68. Global Complement C5 Recombinant Monoclonal Antibody Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Complement C5 Recombinant Monoclonal Antibody Price (US$/Unit) by Application (2027–2032)
 Table 70. Regeneron Pharmaceuticals Company Information
 Table 71. Regeneron Pharmaceuticals Description and Business Overview
 Table 72. Regeneron Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Regeneron Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Product
 Table 74. Regeneron Pharmaceuticals Recent Developments/Updates
 Table 75. Alexion Pharmaceuticals Company Information
 Table 76. Alexion Pharmaceuticals Description and Business Overview
 Table 77. Alexion Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Alexion Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Product
 Table 79. Alexion Pharmaceuticals Recent Developments/Updates
 Table 80. Amgen Company Information
 Table 81. Amgen Description and Business Overview
 Table 82. Amgen Complement C5 Recombinant Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Amgen Complement C5 Recombinant Monoclonal Antibody Product
 Table 84. Amgen Recent Developments/Updates
 Table 85. Samsung Bioepis Company Information
 Table 86. Samsung Bioepis Description and Business Overview
 Table 87. Samsung Bioepis Complement C5 Recombinant Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Samsung Bioepis Complement C5 Recombinant Monoclonal Antibody Product
 Table 89. Samsung Bioepis Recent Developments/Updates
 Table 90. Roche Company Information
 Table 91. Roche Description and Business Overview
 Table 92. Roche Complement C5 Recombinant Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Roche Complement C5 Recombinant Monoclonal Antibody Product
 Table 94. Roche Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Complement C5 Recombinant Monoclonal Antibody Distributors List
 Table 98. Complement C5 Recombinant Monoclonal Antibody Customers List
 Table 99. Complement C5 Recombinant Monoclonal Antibody Market Trends
 Table 100. Complement C5 Recombinant Monoclonal Antibody Market Drivers
 Table 101. Complement C5 Recombinant Monoclonal Antibody Market Challenges
 Table 102. Complement C5 Recombinant Monoclonal Antibody Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Complement C5 Recombinant Monoclonal Antibody
 Figure 2. Global Complement C5 Recombinant Monoclonal Antibody Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Complement C5 Recombinant Monoclonal Antibody Market Share by Type: 2025 & 2032
 Figure 4. Crovalimab Product Picture
 Figure 5. Ravulizumab Product Picture
 Figure 6. Eculizumab Product Picture
 Figure 7. Pozelimab Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Complement C5 Recombinant Monoclonal Antibody Market Value by Application (US$ Million), 2021–2032
 Figure 10. Global Complement C5 Recombinant Monoclonal Antibody Market Share by Application: 2025 & 2032
 Figure 11. PNH
 Figure 12. aHUS
 Figure 13. CD55 Deficiency
 Figure 14. Others
 Figure 15. Global Complement C5 Recombinant Monoclonal Antibody Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 16. Global Complement C5 Recombinant Monoclonal Antibody Market Size (US$ Million), 2021–2032
 Figure 17. Global Complement C5 Recombinant Monoclonal Antibody Sales (K Units), 2021–2032
 Figure 18. Global Complement C5 Recombinant Monoclonal Antibody Average Price (US$/Unit), 2021–2032
 Figure 19. Complement C5 Recombinant Monoclonal Antibody Report Years Considered
 Figure 20. Complement C5 Recombinant Monoclonal Antibody Sales Share by Manufacturers in 2025
 Figure 21. Global Complement C5 Recombinant Monoclonal Antibody Revenue Share by Manufacturers in 2025
 Figure 22. Top 5 and Top 10 Global Complement C5 Recombinant Monoclonal Antibody Players: Market Share by Revenue in Complement C5 Recombinant Monoclonal Antibody in 2025
 Figure 23. Complement C5 Recombinant Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 24. Global Complement C5 Recombinant Monoclonal Antibody Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 25. North America Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Country (2021–2032)
 Figure 26. North America Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Country (2021–2032)
 Figure 27. United States Complement C5 Recombinant Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. Canada Complement C5 Recombinant Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Europe Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Country (2021–2032)
 Figure 30. Europe Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Country (2021–2032)
 Figure 31. Germany Complement C5 Recombinant Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. France Complement C5 Recombinant Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. U.K. Complement C5 Recombinant Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Italy Complement C5 Recombinant Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Russia Complement C5 Recombinant Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Asia Pacific Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Region (2021–2032)
 Figure 37. Asia Pacific Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Region (2021–2032)
 Figure 38. China Complement C5 Recombinant Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Japan Complement C5 Recombinant Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. South Korea Complement C5 Recombinant Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. India Complement C5 Recombinant Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Australia Complement C5 Recombinant Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. China Taiwan Complement C5 Recombinant Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Southeast Asia Complement C5 Recombinant Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Latin America Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Country (2021–2032)
 Figure 46. Latin America Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Country (2021–2032)
 Figure 47. Mexico Complement C5 Recombinant Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Brazil Complement C5 Recombinant Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Argentina Complement C5 Recombinant Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Colombia Complement C5 Recombinant Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Country (2021–2032)
 Figure 52. Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Country (2021–2032)
 Figure 53. Turkey Complement C5 Recombinant Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Saudi Arabia Complement C5 Recombinant Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. UAE Complement C5 Recombinant Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. Global Sales Market Share of Complement C5 Recombinant Monoclonal Antibody by Type (2021–2032)
 Figure 57. Global Revenue Market Share of Complement C5 Recombinant Monoclonal Antibody by Type (2021–2032)
 Figure 58. Global Complement C5 Recombinant Monoclonal Antibody Price (US$/Unit) by Type (2021–2032)
 Figure 59. Global Sales Market Share of Complement C5 Recombinant Monoclonal Antibody by Application (2021–2032)
 Figure 60. Global Revenue Market Share of Complement C5 Recombinant Monoclonal Antibody by Application (2021–2032)
 Figure 61. Global Complement C5 Recombinant Monoclonal Antibody Price (US$/Unit) by Application (2021–2032)
 Figure 62. Complement C5 Recombinant Monoclonal Antibody Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Complement Inhibitors Market Research Report 2024
Global Eculizumab Market Research Report 2024
Global Complement Protein C3 Inhibitors Market Research Report 2024
Global Complement C4 Antibody Market Research Report 2024
C5 Complement Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Rabbit Monoclonal Antibodies Market Research Report 2025
XRCC5 Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Monoclonal Antibody Biologics and Biosimilars Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Blocking Antibodies Market Research Report 2024
Biologics Monoclonal Antibodies Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hepatocellular Carcinoma Monoclonal Antibody Market Research Report 2025
Global Complement Drug for Kidney Disease Market Research Report 2024
Global Treatment of PNH Market Research Report 2024
Global Drugs for PNH Market Research Report 2024
Global Monoclonal Antibodies for Alzheimer Disease Market Research Report 2024
Global Rituximab Biosimilars Market Research Report 2025
Global Omalizumab Monoclonal Antibody Biosimilars Market Research Report 2024
Global Therapeutic Monoclonal Antibodies Market Research Report 2024
Global Hemophilia monoclonal antibody Market Research Report 2024
Global Complement Deficiency Tests Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions